[Ultrastructure of the blood lymphoid cells and the dynamics of cellular immunity indices in chronic lympholeukemia patients during immunocorrection with T-activin].
Fourteen patients with chronic lymphoid leukemia who received treatment with T-activin given in courses (800-1100 micrograms) were examined for ultrastructure of blood lymphoid cells and the time-course of changes in humoral immunity. The patients had not received chemotherapy or hormonal treatment before. During the treatment with T-activin, no chemotherapeutic remedies were administered. After immunocorrection chemotherapy and hormones were prescribed when necessary. In the patients, the number of E-RFC (T cells) rose, whereas the number of B cells carrying surface immunoglobulins and the number of Em-RFC decreased. At the same time the prolonged use of T-activin brought about an increase in the number of B cells containing heavy chains of immunoglobulins M, G and A in the cytoplasm, while no considerable rise of serum immunoglobulins M, G and A was detected. Ultrastructural studies made during the use T-activin demonstrated a double rise in the number of lymphoplasmocytes, and in that of wide-plasma lymphocytes. The latter ones measuring 10 to 12 microns showed hypertrophy of Golgi's complexes and of the endoplasmic network. It is suggested that administration of T-activin for the B cell version of chronic lympholeukemia produces the differentiation of B cells, accompanied by the appearance in the cytoplasm of heavy chains of immunoglobulins M, G and A, which is supported by immunological and morphological analysis.